Table 3.

Sensitivity analysis: cost-effectiveness of the 3D approach from an NHS/PSS perspective based on complete cases only

	Usual care mean (SE) n=592 complete cases	Intervention mean (SE) n=599 complete cases	Incremental difference (95% CI)
Costs (£)
Unadjusted costs from the NHS/PSS perspective	4916 (290)	4757 (222)
Adjusted costs from the NHS/PSS perspective	4905 (258)	4768 (256)	−137 (−852 to 577)
Outcomes
Unadjusted QALYs over 15 months of follow-up	0.698 (0.014)	0.750 (0.013)
Adjusted QALYs over 15 months of follow-up	0.722 (0.005)	0.726 (0.005)	0.004 (−0.010 to 0.019)
Cost-effectiveness statistics
ICER: Intervention dominates
Net monetary benefit at £20,000: £222 (−584 to 1028).

Cost estimates were adjusted for randomisation variables; QALY estimates were adjusted for randomisation variables and baseline utility.

CI, confidence interval; ICER, incremental cost-effectiveness ratio; NHS, National Health Service; PSS, personal social services; QALY, quality-adjusted life year; SE, standard error.